Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor

In this study, the authors show that MeCP2 interacts with the NCoR/SMRT co-repressor complex and that a discrete cluster of Rett syndrome–causing mutations in the C-terminal domain of MeCP2 disrupts this interaction, impairing transcriptional repression. Knock-in mice expressing one of these MeCP2 m...

Full description

Saved in:
Bibliographic Details
Published inNature neuroscience Vol. 16; no. 7; pp. 898 - 902
Main Authors Lyst, Matthew J, Ekiert, Robert, Ebert, Daniel H, Merusi, Cara, Nowak, Jakub, Selfridge, Jim, Guy, Jacky, Kastan, Nathaniel R, Robinson, Nathaniel D, de Lima Alves, Flavia, Rappsilber, Juri, Greenberg, Michael E, Bird, Adrian
Format Journal Article
LanguageEnglish
Published New York Nature Publishing Group US 01.07.2013
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this study, the authors show that MeCP2 interacts with the NCoR/SMRT co-repressor complex and that a discrete cluster of Rett syndrome–causing mutations in the C-terminal domain of MeCP2 disrupts this interaction, impairing transcriptional repression. Knock-in mice expressing one of these MeCP2 missense mutations exhibit severe motor phenotypes. Rett syndrome (RTT) is a severe neurological disorder that is caused by mutations in the MECP2 gene. Many missense mutations causing RTT are clustered in the DNA-binding domain of MeCP2, suggesting that association with chromatin is critical for its function. We identified a second mutational cluster in a previously uncharacterized region of MeCP2. We found that RTT mutations in this region abolished the interaction between MeCP2 and the NCoR/SMRT co-repressor complexes. Mice bearing a common missense RTT mutation in this domain exhibited severe RTT-like phenotypes. Our data are compatible with the hypothesis that brain dysfunction in RTT is caused by a loss of the MeCP2 'bridge' between the NCoR/SMRT co-repressors and chromatin.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
AUTHOR CONTRIBUTIONS M.J.L. carried out protein purification for mass spectrometry, deletion analysis and mutation analysis. R.E. performed protein purification for mass spectrometry and repression assays. C.M. produced Mecp2R306C-EGFP knock-in ES cells, performed neuronal differentiation and immunofluorescence analysis. J.N. performed in vitro protein binding assays. J.G. and J.S. produced Mecp2-EGFP knock-in mice and Mecp2T158M-EGFP ES cells. F.d.L.A. and J.R. performed mass spectrometry analysis. D.H.E., N.R.K., N.D.R. and M.E.G. generated and phenotyped Mecp2R306C knock-in mice. M.J.L., R.E. and A.B. wrote the manuscript.
ISSN:1097-6256
1546-1726
DOI:10.1038/nn.3434